Literature DB >> 12412739

The current status of neutrophil cytoplasmic antibodies.

F J van der Woude1, M R Daha, L A van Es.   

Abstract

Several studies in the past 10 years have demonstrated the occurrence of autoantibodies against cytoplasmic constituents in patients with vasculitis and glomerulonephritis. In this review the nomenclature of these antibodies is discussed and assays and clinical associations are summarized. Although the antigens involved are not completely identified, antibodies and T cells reactive with myeloid lysozomal enzymes may both play a significant role in pathogenesis.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 12412739      PMCID: PMC1534659     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  36 in total

1.  The spectrum of vasculitis: clinical, pathologic, immunologic and therapeutic considerations.

Authors:  A S Fauci; B Haynes; P Katz
Journal:  Ann Intern Med       Date:  1978-11       Impact factor: 25.391

2.  ELISA examination for IgG-ANCA in sera submitted for the 1st international workshop on ANCA.

Authors:  N Rasmussen; J Lüdemann; B Utecht
Journal:  APMIS Suppl       Date:  1989

3.  Granulocyte-specific antinuclear factors in synovial fluids and sera from patients with rheumatoid arthritis.

Authors:  A Wiik; E Jensen; J Friis
Journal:  Ann Rheum Dis       Date:  1974-11       Impact factor: 19.103

4.  Immunological features of Wegener's granulomatosis.

Authors:  E J Shillitoe; T Lehner; M H Lessof; D F Harrison
Journal:  Lancet       Date:  1974-02-23       Impact factor: 79.321

5.  Wegener's granulomatosis. A clinicopathological study in twelve patients.

Authors:  F J van der Woude; L Arisz; S Meijer; A J Donker; P J Hoedemaeker; J J van Overbeek
Journal:  Neth J Med       Date:  1978       Impact factor: 1.422

6.  Relapses in Wegener's granulomatosis: the role of infection.

Authors:  A J Pinching; A J Rees; B A Pussell; C M Lockwood; R S Mitchison; D K Peters
Journal:  Br Med J       Date:  1980-09-27

7.  Renal involvement in Wegener's granulomatosis. Report of three unusual cases.

Authors:  F J van der Woude; S J Hoorntje; J J Weening; J J van Overbeek; G K van der Hem
Journal:  Nephron       Date:  1982       Impact factor: 2.847

8.  Association of Wegener's granulomatosis with HLA-B8.

Authors:  P Katz; D W Alling; B F Haynes; A S Fauci
Journal:  Clin Immunol Immunopathol       Date:  1979-10

9.  Immune complex disease. 3. The granulomatous manifestations.

Authors:  F G Germuth; A D Pollack
Journal:  Johns Hopkins Med J       Date:  1967-10

10.  An ultrastructural study of the pathogenesis of tissue injury in limited Wegener's granulomatosis.

Authors:  K J Donald; R L Edwards; J D McEvoy
Journal:  Pathology       Date:  1976-04       Impact factor: 5.306

View more
  24 in total

Review 1.  The antigenic significance and methods of detection of the anti-neutrophil cytoplasmic autoantibodies (ANCA).

Authors:  X Bosch; R A Asherson
Journal:  Postgrad Med J       Date:  1992-09       Impact factor: 2.401

2.  Clinical significance of antibodies against neutrophils in patients with inflammatory bowel disease and primary sclerosing cholangitis.

Authors:  F Seibold; P Weber; R Klein; P A Berg; K H Wiedmann
Journal:  Gut       Date:  1992-05       Impact factor: 23.059

3.  Anti-neutrophil cytoplasmic autoantibodies in a child with pauci-immune necrotizing and crescentic glomerulonephritis.

Authors:  L A Baldree; L W Gaber; C P McKay
Journal:  Pediatr Nephrol       Date:  1991-05       Impact factor: 3.714

Review 4.  Clinical immunology.

Authors:  R J Powell
Journal:  Postgrad Med J       Date:  1991-11       Impact factor: 2.401

5.  Antineutrophil antibodies (ANCA)

Authors:  C Feighery; J Jackson
Journal:  Ir J Med Sci       Date:  1991-03       Impact factor: 1.568

6.  Identification and validation of urinary biomarkers for differential diagnosis and evaluation of therapeutic intervention in anti-neutrophil cytoplasmic antibody-associated vasculitis.

Authors:  Marion Haubitz; David M Good; Alexander Woywodt; Hermann Haller; Harald Rupprecht; Dan Theodorescu; Mohammed Dakna; Joshua J Coon; Harald Mischak
Journal:  Mol Cell Proteomics       Date:  2009-06-28       Impact factor: 5.911

7.  Antineutrophil cytoplasmic antibodies in Bulgarian patients with rheumatoid arthritis: characterization and clinical associations.

Authors:  Irena Manolova; Maria Dantcheva
Journal:  Rheumatol Int       Date:  2004-11-11       Impact factor: 2.631

Review 8.  Antineutrophil cytoplasmic autoantibodies: immunobiological aspects.

Authors:  W L Gross; E Csernok; W H Schmitt
Journal:  Klin Wochenschr       Date:  1991-09-03

9.  Binding of proteinase 3 and myeloperoxidase to endothelial cells: ANCA-mediated endothelial damage through ADCC?

Authors:  B E Ballieux; K T Zondervan; P Kievit; E C Hagen; L A van Es; F J van der Woude; M R Daha
Journal:  Clin Exp Immunol       Date:  1994-07       Impact factor: 4.330

10.  Activated neutrophils express proteinase 3 on their plasma membrane in vitro and in vivo.

Authors:  E Csernok; M Ernst; W Schmitt; D F Bainton; W L Gross
Journal:  Clin Exp Immunol       Date:  1994-02       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.